Pharmabiz

Esaote & Schiller Americas announce strategic partnership to expand the sales channel in the cardiology imaging space

Esaote & Schiller Americas announce strategic partnership to expand the sales channel in the cardiology imaging space: ...
Pharmabiz

Kiran Mazumdar-Shaw ranked among India’s generous Women Philanthropists by EdelGive Hurun India Philanthropy List 2025

Kiran Mazumdar-Shaw ranked among India’s generous Women Philanthropists by EdelGive Hurun India Philanthropy List 2025: Our Bureau, Bengaluru Monday, November 17, 2025, 17:40 Hr ...
Pharmabiz

NEB launches NEBNext Flu A Integrated Indexing Primer Module to advance influenza A surveillance and sequencing

Ipswich, Massachusetts Monday, November 17, 2025, 17:00 Hrs [IST] ...
Pharmabiz

CHARM Therapeutics advances CHM-029, a next-generation menin inhibitor for acute myeloid leukaemia

CHARM Therapeutics advances CHM-029, a next-generation menin inhibitor for acute myeloid leukaemia: London Monday, November 17, 2025, 18:00 Hrs [IST] CHARM Therapeutics (CHARM), a ...
Pharmabiz

AstraZeneca Pharma India and Sun Pharma partner to help patients living with hyperkalaemia in India

AstraZeneca Pharma India and Sun Pharma partner to help patients living with hyperkalaemia in India: Our Bureau, Bengaluru Monday, November 17, 2025, 17:20 Hrs [IST] AstraZeneca P ...
Pharmabiz

Whale Tank Biocatalysts unveils NexaSweet, an innovative, stem cell attractant-based sweetener for gut inflammation

Whale Tank Biocatalysts unveils NexaSweet, an innovative, stem cell attractant-based sweetener for gut inflammation: Our Bureau, Bengaluru Monday, November 17, 2025, 16:30 Hrs [IS ...
Pharmabiz

Union Ayush Ministry shares CARI Bengaluru's diabetes success with Pharmabiz

Union Ayush Ministry shares CARI Bengaluru's diabetes success with Pharmabiz: Our Bureau, Chennai Monday, November 17, 2025, 16:15 Hrs [IST] The media wing of the Union Ayush Mini ...
Pharmabiz

Sarepta Therapeutics reports US FDA’s approval of updated Elevidys prescribing information

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, announced an update to the prescribing information for Elevidys (delandistrogene moxeparvovec-rokl), the only ...
Pharmabiz

NORD launches new request for proposals for patient registries

NORD launches new request for proposals for patient registries: Danbury, Connecticut Monday, November 17, 2025, 15:00 Hrs [IST] The National Organization for Rare Disorders (NORD) ...
Pharmabiz

Alembic Pharma receives US FDA final approval for diltiazem HCl tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg

Alembic Pharma receives US FDA final approval for diltiazem HCl tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg: Our Bureau, Mumbai Monday, November 17, 2025, 13:30 Hrs [IST] Alembic ...
Pharmabiz

Adagene inks licensing agreement with Third Arc Bio to develop two masked CD3 T cell engagers utilizing SAFEbody technology

Adagene inks licensing agreement with Third Arc Bio to develop two masked CD3 T cell engagers utilizing SAFEbody technology: San Diego Monday, November 17, 2025, 14:00 Hrs [IST] A ...
Pharmabiz

Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome

Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...